IMarike yeFilimu eNcinci ngoMlomo: Ukunyuka kweMbango yeeNkqubo zokuhanjiswa kweZiyobisi zeFilimu eziNcinci

Ngokwengxelo, imakethi yefilimu yomlomo yehlabathi ixabisa i-USD 2.6 yeebhiliyoni ngo-2019. Izinga lokukhula konyaka ukusuka ku-2020 ukuya ku-2030 kulindeleke ukuba libe malunga ne-9%. Ukubambelela kwi-mucosa yomlomo. Ukunyuka kwemfuno yeenkqubo zokuhanjiswa kwefilimu ecekethekileyo, i-R&D enkulu, kunye nobudlelwane obucwangcisiweyo phakathi kwabanini betekhnoloji entsha kunye neenkampani ezinkulu zamayeza zezona zinto zilindelekileyo ukuba ziqhube imakethi yefilimu yomlomo ebhityileyo yelizwe jikelele kwixesha loqikelelo. ngesabelo esikhulu semakethi yefilimu yomlomo yehlabathi ngo-2019 ngenxa yokungena okuphezulu kwetekhnoloji yefilimu yomlomo kunye nokugxila okwandisiweyo kwimveliso entsha esungulwe ngabadlali boshishino kulo mmandla.

Ukuvelisa-Ixabiso-Automatic-Oral-Thin-Film-Oral-Film-Strip-Making-Machine

Imakethi yefilimu yomlomo eYurophu kulindeleke ukuba ikhule kwi-CAGR ephezulu ye-11.2% ukusuka ngo-2020 ukuya ku-2030 ngenxa yokwanda kwenani labaguli abalupheleyo abaphethwe yi-dysphagia kunye nokwanda kokwaziswa kweefilimu zomlomo kulo mmandla.

Imfuno yeenkqubo zokuhanjiswa kweziyobisi ezicekethekileyo zinyuka ngenxa yeenzuzo ezifana nommandla omkhulu, ukuhanjiswa kweziyobisi ngokuchanekileyo, kunye nombala okholisayo kunye nencasa kuneenkqubo zokuhanjiswa kweziyobisi zemveli.Izidakamizwa zefilimu eziThin zixelwe ukuba zikhethwa kuqala kwizigulane kunye oogqirha bezonyango ngenxa yokuba banomonde ngakumbi kwaye babonelela ngeziphumo ezikumgangatho ophezulu.Amayeza efilimu yomlomo anika ukuthotyelwa kwesigulane esiphezulu kwaye kulula ukuyigcina kunye nokuthutha.Ngaphezu koko, ezi zibonelela ngedosi echanekileyo kunye nechanekileyo kunye neziphumo ezifunwayo ezisebenzayo.Ngoko ke, imarike yokuthengisa Iinkqubo zefilimu ezibhityileyo zokuhanjiswa kweziyobisi zinomtsalane. Ukwamkelwa okuphezulu kunye neenzuzo ezibalulekileyo ziqhubela phambili imarike yefilimu yomlomo yehlabathi.

Ngokwemveliso, imakethi yefilimu yomlomo yehlabathi yahlulwe yaba yifilimu yomlomo engaphantsi kweelwimi, ifilimu yomlomo kwangoko, kunye nefilimu ye-buccal. imisebenzi yophando, umbhobho wemveliso owomeleleyo, kunye nokwamkelwa kwentengiso ephezulu yeefilimu ezingaphantsi kweelwimi kulindeleke ukuba ziqhube icandelo ngexesha lokuqikelela.

Ngokwezibonakaliso, imarike yefilimu yomlomo yehlabathi yahlulwe kulawulo lweentlungu, ukuphazamiseka kwemithambo-luvo, isicaphucaphu kunye nokugabha, ukuxhomekeka kwe-opioid, kunye nabanye. Ukuphazamiseka kwe-neurological kulindeleke ukuba kuqhube icandelo kwixesha eliqikelelweyo.Umndilili wokuxhaphaka kwezifo ze-neurological eIndiya malunga ne-2,394 ngabantu abayi-100,000, ngokutsho kwedatha epapashwe liZiko leSizwe loLwazi lwe-Biotechnology.
Ngokusekwe kwijelo losasazo, imakethi yefilimu yomlomo yehlabathi yahlulwe kwiikhemesti zesibhedlele, iikhemesti ezithengisayo, kunye neekhemesti ezikwi-Intanethi. iikhemesti ezithengisa kumazwe asakhasayo.
Ngokwemimandla, imarike yefilimu yomlomo yehlabathi yahlulwe kuMntla Melika, iYurophu, iLatin America, iAsia Pacific, kunye noMbindi Mpuma kunye neAfrika. UMntla Melika kulindeleke ukuba uphendule ngesabelo esikhulu semakethi yefilimu yomlomo yehlabathi ngexesha Ukungena okuphezulu kweefilimu zomlomo, ukufumaneka kwemveliso, kunye nobukho benani elikhulu lababoneleli zezona zinto ziqhuba imarike kulo mmandla xa kuthelekiswa neminye imimandla. ikamva ngenxa yobukho babadlali basekhaya nabehlabathi kunye nokwanda kwemfuno yeefilimu zomlomo kummandla. Imarike yefilimu yomlomo yaseYurophu ilindeleke ukuba yande ngokukhawuleza kwixesha elizayo elingekude. IJapan kunye neTshayina kulindeleke ukuba zibe ziimarike ezinengeniso yeefilimu zomlomo ngexesha loqikelelo. Ubukho benani elikhulu labaguli abane-dysphagia kula mazwe kunye nokwanda kwenkcitho kukhathalelo lwempilo kulindeleke ukuba kuqhube imakethi e-Asia Pacific kule minyaka imbalwa izayo.
Abadlali abaphambili abasebenza kwintengiso yefilimu yomlomo yehlabathi yiZIM Laboratories Limited, Indivior plc, Aquestive Therapeutics, Inc., LIVKON Pharmaceuticals pvt.Ltd, Shilpa Therapeutics Pvt.Ltd, Sunovion Pharmaceuticals, Inc., NAL Pharma, Cure Pharmaceuticals ., UGqr. Reddy's Laboratories, iKyu Pharmaceutical Co Ltd, iSeoul PharmaCo kunye ne-CL Pharm.Ezi nkampani zibandakanya uphando kunye nophuhliso lokuphuhlisa iimveliso ezintsha zokwandisa imveliso yemveliso kunye ne-custo.


Ixesha lokuposa: May-16-2022

Iimveliso ezinxulumeneyo